Simonida Crvenkova

Skopje, 1000, The former Yugoslav Republic of Macedonia

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

Genetic Alteration Profiling in North Macedonian Lung Cancer Patients.

Genetic Alteration Profiling in North Macedonian Lung Cancer Patients.

Journal: Genes
Published: July 17, 2025

Osimertinib-Induced Toxic Epidermal Necrolysis - A Case Report.

Osimertinib-Induced Toxic Epidermal Necrolysis - A Case Report.

Journal: Prilozi (Makedonska akademija na naukite i umetnostite. Oddelenie za medicinski nauki)
Published: December 12, 2024

Review of Lung Cancer Patient Characteristics and Treatment Strategies in the Pandemic Covid-19 Year.

Review of Lung Cancer Patient Characteristics and Treatment Strategies in the Pandemic Covid-19 Year.

Journal: Prilozi (Makedonska akademija na naukite i umetnostite. Oddelenie za medicinski nauki)
Published: March 29, 2023

Alectinib Treatment of ALK Positive Non Small Cell Lung Cancer Patients with Brain Metastases: Our Clinical Experience.

Alectinib Treatment of ALK Positive Non Small Cell Lung Cancer Patients with Brain Metastases: Our Clinical Experience.

Journal: Prilozi (Makedonska akademija na naukite i umetnostite. Oddelenie za medicinski nauki)
Published: October 04, 2020

Survival and Side Effects in Non-Small Cell Lung Cancer Patients Treated With Combination of Chemotherapy and Conformal Radiotherapy.

Survival and Side Effects in Non-Small Cell Lung Cancer Patients Treated With Combination of Chemotherapy and Conformal Radiotherapy.

Journal: Open access Macedonian journal of medical sciences
Published: October 14, 2018

Correlation Between Microvessel Density and Morphological Features in Skin Squamous Cell Carcinoma.

Correlation Between Microvessel Density and Morphological Features in Skin Squamous Cell Carcinoma.

Journal: Prilozi (Makedonska akademija na naukite i umetnostite. Oddelenie za medicinski nauki)
Published: June 09, 2017

Important prognostic factors for the long-term survival in non-small cell lung cancer patients treated with combination of chemotherapy and conformal radiotherapy.

Important prognostic factors for the long-term survival in non-small cell lung cancer patients treated with combination of chemotherapy and conformal radiotherapy.

Journal: Journal of B.U.ON. : official journal of the Balkan Union of Oncology
Published: July 28, 2015

Prognostic Factors and Survival in Non-Small Cell Lung Cancer Patients Treated with Chemoradiotherapy.

Prognostic Factors and Survival in Non-Small Cell Lung Cancer Patients Treated with Chemoradiotherapy.

Journal: Open access Macedonian journal of medical sciences
Published: October 28, 2014

Epidemiological analysis of progression-free survival (PFS) and overall survival (OS) in non-small-cell lung cancer patients in Republic of Macedonia.

Epidemiological analysis of progression-free survival (PFS) and overall survival (OS) in non-small-cell lung cancer patients in Republic of Macedonia.

Journal: Prilozi (Makedonska akademija na naukite i umetnostite. Oddelenie za medicinski nauki)
Published: February 26, 2014

Effectiveness of erlotinib as a second line therapy for patients with epidermal growth factor receptor (EGFR) mutation in non-small cell lung cancer (NSCLC): our clinical experience.

Effectiveness of erlotinib as a second line therapy for patients with epidermal growth factor receptor (EGFR) mutation in non-small cell lung cancer (NSCLC): our clinical experience.

Journal: Prilozi
Published: September 18, 2012

Prognostic factors in patients with advanced hypopharyngeal squamous cell carcinoma treated with concurrent chemoradiotherapy.

Prognostic factors in patients with advanced hypopharyngeal squamous cell carcinoma treated with concurrent chemoradiotherapy.

Journal: Journal of B.U.ON. : official journal of the Balkan Union of Oncology
Published: June 29, 2012
Showing 1-11 of 11

Last Updated: 09/26/2026